Muntean Ioana Adriana, Bocsan Ioana Corina, Deleanu Diana
Department of Immunology and Allergology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Iran J Allergy Asthma Immunol. 2018 Jun;17(3):291-294.
Wheat is the most commonly grown cereal. Immunological reaction to wheat may be IgE or T-cell- mediated. Asthma could be induced by inhaled flour or by exposure to allergens present in bakery products. In patients with IgE-mediated allergy to wheat proteins there is no specific therapy, except oral immunotherapy (OIT). There are few data regarding OIT with wheat protein in allergic patients. We present a case of a 32-yearold female patient, who worked for 5 years in wheat and bakery products industry, who developed an occupational asthma and chronic urticaria after flour inhalation or ingestion of foods that containit. The patient underwent wheat OIT, that was well-tolerated with no severe reaction during treatment. We may conclude that wheat OIT is a safe therapy and may induce symptoms improvement in allergic asthma and urticaria in patients with wheat allergy. Wheat OIT may induce tolerance to allergic patients.
小麦是种植最为广泛的谷物。对小麦的免疫反应可能由IgE或T细胞介导。吸入面粉或接触烘焙食品中的过敏原可能诱发哮喘。对于对小麦蛋白有IgE介导过敏反应的患者,除了口服免疫疗法(OIT)外没有其他特效疗法。关于小麦蛋白口服免疫疗法用于过敏患者的数据较少。我们报告一例32岁女性患者,她在小麦和烘焙食品行业工作了5年,在吸入面粉或摄入含面粉的食物后患上了职业性哮喘和慢性荨麻疹。该患者接受了小麦口服免疫疗法,治疗期间耐受性良好,未出现严重反应。我们可以得出结论,小麦口服免疫疗法是一种安全的治疗方法,可能会改善小麦过敏患者过敏性哮喘和荨麻疹的症状。小麦口服免疫疗法可能会使过敏患者产生耐受性。